- Home
- NEGG vs CERT Comparison
NEGG vs CERT Comparison
Compare NEGG & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEGG | CERT |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | United States |
| Employees | 762 | N/A |
| Industry | Other Specialty Stores | Retail: Computer Software & Peripheral Equipment |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.1M | 860.9M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NEGG | CERT |
|---|---|---|
| Price | $17.67 | $5.86 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 86.1K | ★ 3.5M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | N/A | $4.18 |
| Revenue Next Year | N/A | $5.39 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $4.84 | $4.45 |
| 52 Week High | $137.84 | $13.88 |
Technical Indicators
Market Signals| Indicator | NEGG | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 21.21 | 58.09 |
| Support Level | N/A | $5.19 |
| Resistance Level | $58.12 | $6.47 |
| Average True Range (ATR) | 1.98 | 0.36 |
| MACD | -0.02 | 0.11 |
| Stochastic Oscillator | 11.14 | 88.68 |
Price Performance
Historical ComparisonAbout NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.